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Small supernumerary marker chromosomes (sSMCs) are
small supernumerary aberrant chromosomes that are
generally equal in size or smaller than a chromosome 20,
and cannot be identified or characterized by conven-
tional cytogenetic banding techniques [1–3].  sSMCs can
appear in 0.044% of newborn infants and in 0.075% of
prenatal cases [1,3,4]. About 70% of sSMCs are caused
by a de novo event [5], about 70% of sSMCs are origi-
nated from acrocentric chromosomes [1,6], and about
70% of de novo sSMCs are associated with no phenotypic
effects [4]. Prenatal diagnosis of sSMCs gives rise to
difficulties in genetic counseling, and identification of
the nature of the aberrant chromosome requires
molecular cytogenetic technologies [4,7–10]. We pres-
ent our experience of the prenatal diagnosis and molec-
ular cytogenetic characterization of an sSMC derived
from chromosome 21 using fluorescence in situ
hybridization (FISH) and multiplex ligation-dependent
probe amplification (MLPA).
A 36-year-old woman, gravida 2, para 1, underwent
amniocentesis at 17 weeks of gestation because of
advanced maternal age. Amniocentesis revealed an
sSMC, which was C-band positive and nucleolar organ-
izing region-stain positive. The parental karyotypes
were normal. The karyotype was 47,XX,+mar (Figure 1). 
The sSMC hybridized with a centromere 13/21-specific 
α-satellite DNA probe (D13Z1/D21Z1) (cep13/21)
(Cytocell, Adderbury, Oxfordshire, UK) (Figure 2). MLPA
was used to determine the origin of the sSMC using a
SALSA MLPA P181 centromere kit (MRC-Holland,
Amsterdam, the Netherlands) (Figure 3). The results
of MLPA indicated a duplication of the 21q11.2 segment
containing the STCH and SAMSN1 genes. FISH determi-
nation of the duplications of the STCH and SAMSN1
genes was performed using the bacterial artificial chro-
mosome clone probes RP11-138O15 and RP11-392H8
at 21q11.2. FISH determination of 21q21.1 involvement
utilized the 21q21.1-specific bacterial artificial chromo-
some clone probes RP11-89M24 and RP11-109H14.
FISH revealed STCH and SAMSN1 gene duplications in
the fetus with sSMC(21) (Figure 4). No RP11-89M24- or
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Figure 1. The G-banded karyotype. mar=marker chromosome.
RP11-109H14-positive hybridization signals were
detected on the sSMC (Figure 5). The karyotype was
47,XX,+mar .ish der(21)(D13Z1/D21Z1+,RP11-138
O15+,RP11-392H8+,RP11-89M24-,RP11-109H14-)
.mlpa 21q11.2(P181) × 3, or 47,XX,+min(21)(pter
q11.2:). Level II ultrasound findings were unremarkable,
but the parents elected to terminate the pregnancy.
This case shows the limitations of the cep13/21
(D13Z1/D21Z1) probe and the usefulness of the MLPA
centromere kit for the identification of an sSMC derived
from chromosome 21. The cep13/21 probe, along with
cep14/22 and cep15, can be used for the rapid identi-
fication of an acrocentric chromosome-derived sSMC
with positive C-banding and nucleolar organizing region-
staining. However, cep13/21 recognizes the centromeres
of both chromosomes 13 and 21. MLPA was first de-
scribed by Schouten et al [11]. It is a molecular method
suitable for detecting gene dosage abnormalities in a
wide range of conditions using relative quantification
of multiple DNA target sequences in one polymerase
chain reaction. It requires an input of 20 ng or more of
DNA, but no living cells or cell cultures. It can be auto-
mated and can produce results in as little as 30 hours
[12]. MLPA involves the amplification and quantification
of the probes added to the samples [13]. An MLPA kit
for rapid aneuploidy diagnosis is commercially available.
The SALSA MLPA P181 centromere kit (MRC-Holland,
Amsterdam, the Netherlands) contains one probe for
the short arm and one probe for the long arm of chro-
mosomes other than acrocentric chromosomes, and
two probes for the long arm of chromosomes 13, 14,
15, 21 and 22 (MRC-Holland). Each probe is close to
the centromere of a specific chromosome. The P181
centromere kit contains 46 different probes and is
designed to detect deletions/duplications of the desig-
nated pericentromeric regions of each chromosome.
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Figure 2. Fluorescence in situ hybridization using an α-satellite
probe D13Z1/D21Z1 (cep13/21) (spectrum red) showing
positive hybridization signals on two chromosomes 13, two
chromosomes 21 and the marker chromosome (mar).
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Figure 3. Multiplex ligation-dependent probe amplification using a SALSA MLPA P181 centromere kit showing three copies
of two targets on chromosome 21q11.2, consistent with the diagnosis of marker chromosome 21 and a duplication of
21q11.2.
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Figure 4. Fluorescence in situ hybridization using 21q11.2-
specific bacterial artificial chromosome clone probes RP11-
138O15 (spectrum green) encompassing the STCH gene and
RP11-392H8 (spectrum red) encompassing the SAMSN1 gene
showing positive hybridization signals on two chromosomes
21 and the marker chromosome (mar), indicating duplica-
tions of the STCH and SAMSN1 genes.
For chromosome 21, the designated regions are STCH
and SAMSN1 at 21q11.2. This MLPA centromere kit is
especially useful for rapidly identifying the chromo-
some origin of an sSMC. In addition to MLPA, array
comparative genomic hybridization (aCGH) is able to
detect DNA dosage imbalances, including deletions
and duplications, in the pericentromeric euchromatic
regions and is useful for the characterization of the
genomic imbalance in sSMC.
About 13% of SMCs are derived from chromosomes
13 and 21 [14]. In a study of 137 patients with SMCs,
Crolla et al [14] found that 59.1% (81/137) were mosaic
and 40.9% (56/137) were non-mosaic. One hundred
and nine cases had known parental origins, 69.7% (76/
109) were de novo, 19.3% (21/109) were maternally in-
herited, and 11.0% (12/109) were paternally inherited.
Among 112 SMCs with FISH results, Crolla et al [14]
found that 34.8% (39/112) were SMC(15), 12.5% (14/
112) were SMC(13/21), 11.6% (13/112) were SMC(14),
and 8.9% (10/112) were SMC(22). The current case had
a duplication encompassing only the 21q11.2 region,
with no involvement of the Down syndrome critical
region. The Down syndrome critical region has been
designated as 21q22qter and is hypothesized to har-
bor the most influential genes, of which extra copies are
responsible for most of the features of Down syndrome
[15,16].
To date, at least eight patients with an sSMC(21)
derived from inv dup(21)(q10)-(q11.2), min(21)(pter-
:p11.1q11.2:-q21.1:), der(21)t(21;22)(q11.1;p11.2)
or r(21)(::p11.2q21.1::) have been documented,
with no clinical findings [17]. However, at least 12
patients with an sSMC(21) derived from inv dup(21)
(q21.1)-(q21.2), inv dup(21)(p10), or min(21)(pter
q11.2:-q11.2∼21.1:-q21.1:-q22.1:-q22.13:) have been
documented with clinical findings [17]. Duplication of
21q11.2 and/or 21q21.1 can be associated with phe-
notypic abnormalities. Baldwin et al [18] reported an
SMC(21) with 50% mosaicism for 1.6 Mb pericentro-
meric constitutional euchromatin encompassing 6–10
genes at 21pq11.2 in a postnatal case with fine motor
skill difficulty, mild dysmorphic features, and a small
penis. Liehr [17] reported a 62-year-old man who had
25% mosaicism for min(21)(pterq11.2∼21.1:) with
psychomotor retardation, severe developmental delay,
no sexual development, short stature, microcephaly,
brachycephaly, a large nose and behavioral problems.
Liehr [17] also reported a newborn boy with 33% mo-
saicism for min(21)(pterq11.2∼21.1:) with scoliosis,
fine motor skill delay, eating problems, and a depressed
nasal bridge, and a 2-year-old boy with an SMC(21) of
der(21) (pterq11.1::q11.1p11.1 or p11.1q11.1::
p12q21.1:) and developmental delay. Prenatal diag-
nosis of sSMC(21) has remained a diagnostic challenge
and should alert clinicians to the possibility of Down
syndrome with the involvement of gene dosage increases
in the Down syndrome critical region.
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